A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo
Latest Information Update: 24 May 2024
At a glance
- Drugs ICM-203 (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Adverse reactions
- Sponsors ICM
Most Recent Events
- 24 Mar 2023 Status changed from not yet recruiting to recruiting.
- 07 Mar 2023 New trial record